Treatment-Resistant Depression: Financial Support for Esketamine Therapy
Recommendations that can help clinicians navigate through the reimbursement process and best support patients who receive intranasal esketamine for treatment-resistant depression.
EP: 1.Prevalence of Treatment-Resistant Depression
EP: 2.IV Ketamine for Treatment-Resistant Depression
EP: 3.Current Guidelines for Managing Treatment-Resistant Depression
EP: 4.Intranasal Esketamine for Treatment-Resistant Depression
EP: 5.Esketamine for Treatment-Resistant Depression: Patient Selection Criteria
EP: 6.Monitoring Patients on Esketamine Therapy for Treatment-Resistant Depression
EP: 7.Response to Esketamine Therapy for Treatment-Resistant Depression
EP: 8.REMS Safety Program for Esketamine in Treatment-Resistant Depression
EP: 9.Treatment-Resistant Depression: Administering Esketamine to Patients
EP: 10.Getting Certified to Administer Esketamine for Treatment-Resistant Depression
EP: 11.Incorporating Esketamine into Practice for Treatment-Resistant Depression
Now Viewing
EP: 12.Treatment-Resistant Depression: Financial Support for Esketamine Therapy
EP: 13.Frontline Psychotherapy for Depression
EP: 14.Traditional Classes of Antidepressant Therapies
EP: 15.Electroconvulsive Therapy for Depression
EP: 16.Integrated Care and Treatment-Resistant Depression
Related Videos
Related Content
